市場調査レポート

商品コード

1593749

ステント市場の評価：製品タイプ・ステントタイプ・材料・タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Stents Market Assessment, By Product Type, By Stent Type, By Material, By Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年11月20日
発行: Markets & Data
ページ情報: 英文 229 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 694,272円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 867,840円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,229,440円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のステントの市場規模は、2023年の126億9,000万米ドルから、予測期間中はCAGR 6.05%で推移し、2031年には203億1,000万米ドルに成長すると予測されています。

同市場の成長を支えているのは、心血管疾患や障害の症例数の増加、新製品の導入に向けた参入事業者による取り組みの強化、高齢者人口の拡大、ステント設計の技術進歩です。

以前は避けられないと考えられていた一連の心臓手術を回避するための新しいステントの導入は、市場に有利な成長機会をもたらしています。2024年10月、FDAは先天性心疾患を持って生まれた子供たちが開心術を回避できるよう、幼児や乳児専用に設計されたステントを承認しました。通常、幼児や乳児がステントを必要とする場合、外科医は大人サイズのステントを修正したり切り詰めたりして、クルミ大の幼児の心臓の血管に押し込んでいます。この方法は、子供が成長すると血管が太くなり、開胸手術でステントを交換することになるため、理想的とは言えませんでした。RENATA MEDICALのMinimaステントは、子供の成長に合わせて大きくなるように設計されており、手術の必要がありません。FDAはまた、2つの心臓疾患 (狭窄と大動脈縮窄) の治療用としてもこれを承認しています。

ライフスタイルの変化と高齢化人口の増加に伴い、心臓疾患の発生は世界のさまざまな地域で増加しており、ステント市場の拡大にプラスの影響を与えています。

当レポートでは、世界のステントの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場リーダー上位5社の競合マトリックス
上位5社のSWOT分析
上位10社の情勢
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- B. Braun SE
- BIOTRONIK SE & Co. KG
- Terumo Group
- Biosensors International Group, Ltd.
- Stryker Corporation
- MicroPort Scientific Corporation
- Cook Group Incorporated

第22章戦略的提言

第23章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Stents Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Stents Market Share (%), By Product Type, 2017-2031F
Figure 3. Global Stents Market Share (%), By Stent Type, 2017-2031F
Figure 4. Global Stents Market Share (%), By Material, 2017-2031F
Figure 5. Global Stents Market Share (%), By Type, 2017-2031F
Figure 6. Global Stents Market Share (%), By End-user, 2017-2031F
Figure 7. Global Stents Market Share (%), By Region, 2017-2031F
Figure 8. North America Stents Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Stents Market Share (%), By Product Type, 2017-2031F
Figure 10. North America Stents Market Share (%), By Stent Type, 2017-2031F
Figure 11. North America Stents Market Share (%), By Material, 2017-2031F
Figure 12. North America Stents Market Share (%), By Type, 2017-2031F
Figure 13. North America Stents Market Share (%), By End-user, 2017-2031F
Figure 14. North America Stents Market Share (%), By Country, 2017-2031F
Figure 15. United States Stents Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Stents Market Share (%), By Product Type, 2017-2031F
Figure 17. United States Stents Market Share (%), By Stent Type, 2017-2031F
Figure 18. United States Stents Market Share (%), By Material, 2017-2031F
Figure 19. United States Stents Market Share (%), By Type, 2017-2031F
Figure 20. United States Stents Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Stents Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Stents Market Share (%), By Product Type, 2017-2031F
Figure 23. Canada Stents Market Share (%), By Stent Type, 2017-2031F
Figure 24. Canada Stents Market Share (%), By Material, 2017-2031F
Figure 25. Canada Stents Market Share (%), By Type, 2017-2031F
Figure 26. Canada Stents Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Stents Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Stents Market Share (%), By Product Type, 2017-2031F
Figure 29. Mexico Stents Market Share (%), By Stent Type, 2017-2031F
Figure 30. Mexico Stents Market Share (%), By Material, 2017-2031F
Figure 31. Mexico Stents Market Share (%), By Type, 2017-2031F
Figure 32. Mexico Stents Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Stents Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Stents Market Share (%), By Product Type, 2017-2031F
Figure 35. Europe Stents Market Share (%), By Stent Type, 2017-2031F
Figure 36. Europe Stents Market Share (%), By Material, 2017-2031F
Figure 37. Europe Stents Market Share (%), By Type, 2017-2031F
Figure 38. Europe Stents Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Stents Market Share (%), By Country, 2017-2031F
Figure 40. Germany Stents Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Stents Market Share (%), By Product Type, 2017-2031F
Figure 42. Germany Stents Market Share (%), By Stent Type, 2017-2031F
Figure 43. Germany Stents Market Share (%), By Material, 2017-2031F
Figure 44. Germany Stents Market Share (%), By Type, 2017-2031F
Figure 45. Germany Stents Market Share (%), By End-user, 2017-2031F
Figure 46. France Stents Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Stents Market Share (%), By Product Type, 2017-2031F
Figure 48. France Stents Market Share (%), By Stent Type, 2017-2031F
Figure 49. France Stents Market Share (%), By Material, 2017-2031F
Figure 50. France Stents Market Share (%), By Type, 2017-2031F
Figure 51. France Stents Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Stents Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Stents Market Share (%), By Product Type, 2017-2031F
Figure 54. Italy Stents Market Share (%), By Stent Type, 2017-2031F
Figure 55. Italy Stents Market Share (%), By Material, 2017-2031F
Figure 56. Italy Stents Market Share (%), By Type, 2017-2031F
Figure 57. Italy Stents Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Stents Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Stents Market Share (%), By Product Type, 2017-2031F
Figure 60. United Kingdom Stents Market Share (%), By Stent Type, 2017-2031F
Figure 61. United Kingdom Stents Market Share (%), By Material, 2017-2031F
Figure 62. United Kingdom Stents Market Share (%), By Type, 2017-2031F
Figure 63. United Kingdom Stents Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Stents Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Stents Market Share (%), By Product Type, 2017-2031F
Figure 66. Russia Stents Market Share (%), By Stent Type, 2017-2031F
Figure 67. Russia Stents Market Share (%), By Material, 2017-2031F
Figure 68. Russia Stents Market Share (%), By Type, 2017-2031F
Figure 69. Russia Stents Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Stents Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Stents Market Share (%), By Product Type, 2017-2031F
Figure 72. Netherlands Stents Market Share (%), By Stent Type, 2017-2031F
Figure 73. Netherlands Stents Market Share (%), By Material, 2017-2031F
Figure 74. Netherlands Stents Market Share (%), By Type, 2017-2031F
Figure 75. Netherlands Stents Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Stents Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Stents Market Share (%), By Product Type, 2017-2031F
Figure 78. Spain Stents Market Share (%), By Stent Type, 2017-2031F
Figure 79. Spain Stents Market Share (%), By Material, 2017-2031F
Figure 80. Spain Stents Market Share (%), By Type, 2017-2031F
Figure 81. Spain Stents Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Stents Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Stents Market Share (%), By Product Type, 2017-2031F
Figure 84. Turkey Stents Market Share (%), By Stent Type, 2017-2031F
Figure 85. Turkey Stents Market Share (%), By Material, 2017-2031F
Figure 86. Turkey Stents Market Share (%), By Type, 2017-2031F
Figure 87. Turkey Stents Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Stents Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Stents Market Share (%), By Product Type, 2017-2031F
Figure 90. Poland Stents Market Share (%), By Stent Type, 2017-2031F
Figure 91. Poland Stents Market Share (%), By Material, 2017-2031F
Figure 92. Poland Stents Market Share (%), By Type, 2017-2031F
Figure 93. Poland Stents Market Share (%), By End-user, 2017-2031F
Figure 94. South America Stents Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Stents Market Share (%), By Product Type, 2017-2031F
Figure 96. South America Stents Market Share (%), By Stent Type, 2017-2031F
Figure 97. South America Stents Market Share (%), By Material, 2017-2031F
Figure 98. South America Stents Market Share (%), By Type, 2017-2031F
Figure 99. South America Stents Market Share (%), By End-user, 2017-2031F
Figure 100. South America Stents Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Stents Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Stents Market Share (%), By Product Type, 2017-2031F
Figure 103. Brazil Stents Market Share (%), By Stent Type, 2017-2031F
Figure 104. Brazil Stents Market Share (%), By Material, 2017-2031F
Figure 105. Brazil Stents Market Share (%), By Type, 2017-2031F
Figure 106. Brazil Stents Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Stents Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Stents Market Share (%), By Product Type, 2017-2031F
Figure 109. Argentina Stents Market Share (%), By Stent Type, 2017-2031F
Figure 110. Argentina Stents Market Share (%), By Material, 2017-2031F
Figure 111. Argentina Stents Market Share (%), By Type, 2017-2031F
Figure 112. Argentina Stents Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Stents Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Stents Market Share (%), By Product Type, 2017-2031F
Figure 115. Asia-Pacific Stents Market Share (%), By Stent Type, 2017-2031F
Figure 116. Asia-Pacific Stents Market Share (%), By Material, 2017-2031F
Figure 117. Asia-Pacific Stents Market Share (%), By Type, 2017-2031F
Figure 118. Asia-Pacific Stents Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Stents Market Share (%), By Country, 2017-2031F
Figure 120. India Stents Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Stents Market Share (%), By Product Type, 2017-2031F
Figure 122. India Stents Market Share (%), By Stent Type, 2017-2031F
Figure 123. India Stents Market Share (%), By Material, 2017-2031F
Figure 124. India Stents Market Share (%), By Type, 2017-2031F
Figure 125. India Stents Market Share (%), By End-user, 2017-2031F
Figure 126. China Stents Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Stents Market Share (%), By Product Type, 2017-2031F
Figure 128. China Stents Market Share (%), By Stent Type, 2017-2031F
Figure 129. China Stents Market Share (%), By Material, 2017-2031F
Figure 130. China Stents Market Share (%), By Type, 2017-2031F
Figure 131. China Stents Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Stents Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Stents Market Share (%), By Product Type, 2017-2031F
Figure 134. Japan Stents Market Share (%), By Stent Type, 2017-2031F
Figure 135. Japan Stents Market Share (%), By Material, 2017-2031F
Figure 136. Japan Stents Market Share (%), By Type, 2017-2031F
Figure 137. Japan Stents Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Stents Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Stents Market Share (%), By Product Type, 2017-2031F
Figure 140. Australia Stents Market Share (%), By Stent Type, 2017-2031F
Figure 141. Australia Stents Market Share (%), By Material, 2017-2031F
Figure 142. Australia Stents Market Share (%), By Type, 2017-2031F
Figure 143. Australia Stents Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Stents Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Stents Market Share (%), By Product Type, 2017-2031F
Figure 146. Vietnam Stents Market Share (%), By Stent Type, 2017-2031F
Figure 147. Vietnam Stents Market Share (%), By Material, 2017-2031F
Figure 148. Vietnam Stents Market Share (%), By Type, 2017-2031F
Figure 149. Vietnam Stents Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Stents Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Stents Market Share (%), By Product Type, 2017-2031F
Figure 152. South Korea Stents Market Share (%), By Stent Type, 2017-2031F
Figure 153. South Korea Stents Market Share (%), By Material, 2017-2031F
Figure 154. South Korea Stents Market Share (%), By Type, 2017-2031F
Figure 155. South Korea Stents Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Stents Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Stents Market Share (%), By Product Type, 2017-2031F
Figure 158. Indonesia Stents Market Share (%), By Stent Type, 2017-2031F
Figure 159. Indonesia Stents Market Share (%), By Material, 2017-2031F
Figure 160. Indonesia Stents Market Share (%), By Type, 2017-2031F
Figure 161. Indonesia Stents Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Stents Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Stents Market Share (%), By Product Type, 2017-2031F
Figure 164. Philippines Stents Market Share (%), By Stent Type, 2017-2031F
Figure 165. Philippines Stents Market Share (%), By Material, 2017-2031F
Figure 166. Philippines Stents Market Share (%), By Type, 2017-2031F
Figure 167. Philippines Stents Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Stents Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Stents Market Share (%), By Product Type, 2017-2031F
Figure 170. Middle East & Africa Stents Market Share (%), By Stent Type, 2017-2031F
Figure 171. Middle East & Africa Stents Market Share (%), By Material, 2017-2031F
Figure 172. Middle East & Africa Stents Market Share (%), By Type, 2017-2031F
Figure 173. Middle East & Africa Stents Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Stents Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Stents Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Stents Market Share (%), By Product Type, 2017-2031F
Figure 177. Saudi Arabia Stents Market Share (%), By Stent Type, 2017-2031F
Figure 178. Saudi Arabia Stents Market Share (%), By Material, 2017-2031F
Figure 179. Saudi Arabia Stents Market Share (%), By Type, 2017-2031F
Figure 180. Saudi Arabia Stents Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Stents Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Stents Market Share (%), By Product Type, 2017-2031F
Figure 183. UAE Stents Market Share (%), By Stent Type, 2017-2031F
Figure 184. UAE Stents Market Share (%), By Material, 2017-2031F
Figure 185. UAE Stents Market Share (%), By Type, 2017-2031F
Figure 186. UAE Stents Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Stents Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Stents Market Share (%), By Product Type, 2017-2031F
Figure 189. South Africa Stents Market Share (%), By Stent Type, 2017-2031F
Figure 190. South Africa Stents Market Share (%), By Material, 2017-2031F
Figure 191. South Africa Stents Market Share (%), By Type, 2017-2031F
Figure 192. South Africa Stents Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Stent Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12261

Global stents market is projected to witness a CAGR of 6.05% during the forecast period 2024-2031, growing from USD 12.69 billion in 2023 to USD 20.31 billion in 2031. The market's growth is supported by the rising cases of cardiovascular diseases and disorders, increasing efforts by the market players to introduce novel products, expansion of the geriatric population, and technological advancements in stent design. Small mesh-like devices are inserted in veins and arteries to keep them open and allow unrestricted fluid and blood flow. Stents are commonly used for treating conditions such as peripheral artery disease and coronary artery disease, among other blockages that can often result in life-threatening complications.

The introduction of new stents to avoid a series of heart operations that were previously considered unavoidable is providing lucrative growth opportunities for the market. In October 2024, the Food and Drug Administration (FDA) approved a stent designed specifically for young children and infants to aid kids born with congenital heart defects in avoiding a series of open-heart operations. Usually, when young children and infants require stents, surgeons modify or trim adult-size stents and squeeze them into the vessels of the infants' hearts, which are approximately the size of a walnut. This method was not ideal as when the child grows older, their blood vessels get bigger, leading to the stents getting replaced in an open-heart surgery. The Minima stent, produced by RENATA MEDICAL, is designed to grow as the child grows, eliminating the surgery requirement. The FDA has also approved it for treating two heart conditions, i.e., stenosis and coarctation.

With increasing lifestyle changes and the growth of the aging population, the occurrence of heart diseases is increasing in different regions across the globe, positively influencing the expansion of the stents market.

Expansion of Geriatric Population to Boost Market Demand

The rapid growth of the aging population is one of the major factors augmenting the requirement for stents from different regions across the globe. As per the estimates of the World Health Organization (WHO), approximately 17.9 million individuals across the globe die from cardiovascular diseases every year. Aging increases the risk of cardiovascular diseases, such as coronary artery disease, atherosclerosis, and hypertension, propelling the requirement for medical intervention and equipment for effective management of heart-related issues. Due to the minimally invasive nature of stenting procedures, they are preferred for older patients who might not be suitable for open heart surgeries due to various age-related complications. Coronary stenting is usually preferred for older people as it allows faster recovery of patients, shorter hospital stays, and minimally invasive alternatives to open heart procedures. The surgical procedures become risky with age, especially if the patients are suffering from coronary artery disease, along with other chronic conditions such as high blood pressure and diabetes. Thus, minimally invasive procedures, including stenting and coronary angioplasty, are more beneficial in elderly patients.

Increasing Investments to Support Market Expansion

The continuous innovations and technological advancements in stent design and manufacturing are providing lucrative growth opportunities to the global stents market. Various medical device companies are actively working on raising investments to propel the development of novel treatment solutions for different cardiac conditions. In February 2024, CeroFlo, an Irish medical device company, announced that they had raised approximately USD 6.9 million (EUR 6.4 million) in investment round funding to advance the development of their novel stent, SubMax device, intended to revolutionize intracranial atherosclerotic disease treatments. The company announced that the funds will aid them in supporting first-in-human clinical trials across thirty patients. Such investments are expected to propel the development and availability of novel technologies, providing lucrative growth opportunities to the market.

Additionally, increasing investments are aiding the leading medical device companies in producing stents that are compatible with the complex anatomical structure of the heart, allowing healthcare professionals to provide customized treatments for patients with varying requirements.

Coronary Stenting to Account for a Significant Market Share

The rising investments by medical device companies in research and development activities for coronary stents are supporting the segment's expansion. The increasing efforts by the leading market players to ensure the availability of coronary stent systems in different regions across the globe are boosting the segment's growth. Additionally, the growing research activities for managing coronary artery perforations further aid the segment's growth. Research institutions across the globe are working on developing a bioresorbable polymer membrane to seal coronary artery perforations effectively. Such coatings could effectively correct symptomatic aneurysms and mitigate neointimal hyperplasia in the vascular lumen.

Coronary stents, including drug-eluting stunts, are increasingly being deployed to treat narrowed or blocked arteries caused by plaque buildup. Additionally, the minimally invasive nature of coronary stenting is bolstering its adoption and providing lucrative growth opportunities to the market. The shorter recovery time, lower risk of complications, and reduced hospital stays associated with the stenting procedure drive the market's demand.

North America to Hold Major Market Share

The increasing awareness among the general population about cardiovascular health, the presence of well-established healthcare infrastructure, and the expansion of the geriatric population are some of the major factors bolstering the growth of the North America stents market. The rising cases of cardiovascular diseases are propelling the market's expansion. According to the estimates by the US Centers for Disease Control and Prevention, 702,880 individuals died from heart disease in 2022. Additionally, the increasing efforts by key market players and research organizations boost the development of innovative devices for different cardiac conditions, providing lucrative growth opportunities to the market.

Meanwhile, the Asia-Pacific market is expected to witness significant growth over the forecast period as an increasing number of patients undergo stenting procedures in countries such as Japan, India, and China due to the expansion of insurance coverage and accessibility to affordable healthcare solutions. Furthermore, the rising awareness about heart health and the importance of regular health checkups and early treatments is propelling the demand for stenting procedures in the region. To meet the rising requirements, local manufacturers are stepping up and producing cost-effective options to increase the accessibility of the procedure for a wider population base.

Future Market Scenario (2024-2031F)

The market is expected to witness significant growth in the forecast years due to the increasing prevalence of cardiovascular diseases, rising partnerships between leading healthcare companies, and growing emphasis on innovation and novel product development. The growing awareness about cardiovascular health and the rapid expansion of the geriatric population is expected to provide lucrative growth opportunities for the market. As per the estimates of the WHO, one in six people across the globe will be 60 years or older by 2030.

Additionally, the market is expected to witness significant growth as different emerging economies, such as South America and Asia-Pacific, invest in improving their healthcare infrastructure. The key market players are expected to increasingly invest in producing more effective and safer stents, improving their designs to cater to the specific requirements of the patient population. The rising emphasis on minimally invasive treatments, in combination with rapid innovations in stent technology, is expected to positively influence the market's expansion.

Key Players Landscape and Outlook

The key players in the market are investing in introducing newer products to expand their market share. In May 2024, Abbott introduced the new generation of XIENCE Sierra Everolimus drug-eluting coronary stent system in India. XIENCE stents are effective in cases of narrow and difficult-to-treat lesions and chronic cases. The improved deliverability and innovative design allow physicians to unblock difficult-to-treat lesions with precision and flexibility. The product contains a highly specialized coating that decreases the probability of arteries re-blocking.

Additionally, the market players are receiving approval from different regulatory bodies, allowing them to distribute their products across the globe and aiding them in expanding their market share. In April 2022, Biosensors International Group, Ltd. announced that they received approval for BioFreedom from the United States FDA and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The BioFreedom stent systems optimize the percutaneous coronary intervention (PCI) procedure for patients with high bleeding risk by simplifying stent choice prior to the procedure. Such approvals are aiding the market players in expanding their global footprint and positively influencing the expansion of the global stents market.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Stents Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product Type
  - 4.2.1.1. Coronary Stenting
  - 4.2.1.2. Peripheral Stenting
- 4.2.2. By Stent Type
  - 4.2.2.1. Bare-Metal Stents
  - 4.2.2.2. Drug-Eluting Stents
  - 4.2.2.3. Bioabsorbable Stents
  - 4.2.2.4. Others
- 4.2.3. By Material
  - 4.2.3.1. Metallic Stents
  - 4.2.3.2. Non-Metallic Stents
- 4.2.4. By Type
  - 4.2.4.1. Self-Expanding Stents
  - 4.2.4.2. Balloon-Expanding Stents
- 4.2.5. By End-user
  - 4.2.5.1. Hospitals
  - 4.2.5.2. Ambulatory Care Centers (ACS)
  - 4.2.5.3. Specialty Clinics
- 4.2.6. By Region
  - 4.2.6.1. North America
  - 4.2.6.2. Europe
  - 4.2.6.3. Asia-Pacific
  - 4.2.6.4. South America
  - 4.2.6.5. Middle East and Africa
- 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Product Type
- 4.3.2. By Stent Type
- 4.3.3. By Material
- 4.3.4. By Type
- 4.3.5. By End-user
- 4.3.6. By Region

5. North America Stents Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product Type
  - 5.2.1.1. Coronary Stenting
  - 5.2.1.2. Peripheral Stenting
- 5.2.2. By Stent Type
  - 5.2.2.1. Bare-Metal Stents
  - 5.2.2.2. Drug-Eluting Stents
  - 5.2.2.3. Bioabsorbable Stents
  - 5.2.2.4. Others
- 5.2.3. By Material
  - 5.2.3.1. Metallic Stents
  - 5.2.3.2. Non-Metallic Stents
- 5.2.4. By Type
  - 5.2.4.1. Self-Expanding Stents
  - 5.2.4.2. Balloon-Expanding Stents
- 5.2.5. By End-user
  - 5.2.5.1. Hospitals
  - 5.2.5.2. Ambulatory Care Centers (ACS)
  - 5.2.5.3. Specialty Clinics
- 5.2.6. By Country Share
  - 5.2.6.1. United States
  - 5.2.6.2. Canada
  - 5.2.6.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Stents Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Product Type
      - 5.3.1.2.1.1. Coronary Stenting
      - 5.3.1.2.1.2. Peripheral Stenting
    - 5.3.1.2.2. By Stent Type
      - 5.3.1.2.2.1. Bare-Metal Stents
      - 5.3.1.2.2.2. Drug-Eluting Stents
      - 5.3.1.2.2.3. Bioabsorbable Stents
      - 5.3.1.2.2.4. Others
    - 5.3.1.2.3. By Material
      - 5.3.1.2.3.1. Metallic Stents
      - 5.3.1.2.3.2. Non-Metallic Stents
    - 5.3.1.2.4. By Type
      - 5.3.1.2.4.1. Self-Expanding Stents
      - 5.3.1.2.4.2. Balloon-Expanding Stents
    - 5.3.1.2.5. By End-user
      - 5.3.1.2.5.1. Hospitals
      - 5.3.1.2.5.2. Ambulatory Care Centers (ACS)
      - 5.3.1.2.5.3. Specialty Clinics
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Stents Market Outlook, 2017-2031F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Stents Market Outlook, 2017-2031F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Stents Market Outlook, 2017-2031F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Stents Market Outlook, 2017-2031F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Medtronic plc
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 21.3.2. Boston Scientific Corporation
- 21.3.3. Abbott Laboratories
- 21.3.4. B. Braun SE
- 21.3.5. BIOTRONIK SE & Co. KG
- 21.3.6. Terumo Group
- 21.3.7. Biosensors International Group, Ltd.
- 21.3.8. Stryker Corporation
- 21.3.9. MicroPort Scientific Corporation
- 21.3.10. Cook Group Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

ステント市場の評価：製品タイプ・ステントタイプ・材料・タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Stents Market Assessment, By Product Type, By Stent Type, By Material, By Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のステント市場の展望

第5章 北米のステント市場の展望

第6章 欧州のステント市場の展望

第7章 アジア太平洋のステント市場の展望

第8章 南米のステント市場の展望

第9章 中東・アフリカのステント市場の展望

第10章 需給分析

第11章 輸出入分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向・展開

第18章 法規制の枠組み・イノベーション

第19章 特許情勢

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的提言

第23章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Stents Market Outlook, 2017-2031F

5. North America Stents Market Outlook, 2017-2031F*

6. Europe Stents Market Outlook, 2017-2031F

7. Asia-Pacific Stents Market Outlook, 2017-2031F

8. South America Stents Market Outlook, 2017-2031F

9. Middle East and Africa Stents Market Outlook, 2017-2031F

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界のステント市場の展望

第5章北米のステント市場の展望

第6章欧州のステント市場の展望

第7章アジア太平洋のステント市場の展望

第8章南米のステント市場の展望

第9章中東・アフリカのステント市場の展望

第10章需給分析

第11章輸出入分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第15章価格分析

第16章市場力学

第17章市場の動向・展開

第18章法規制の枠組み・イノベーション

第19章特許情勢

第20章ケーススタディ

第21章競合情勢

第22章戦略的提言

第23章当社について・免責事項